(Reuters) – The U.S. Food and Drug Administration (FDA) has cleared the first test to detect women with risk of severe preeclampsia, a leading cause of pregnancy-related illness and death in the United States, Thermo Fisher Scientific Inc said on Friday.
(Reporting by Khushi Mandowara in Bengaluru; Editing by Shailesh Kuber)
